2000 SIERRA POINT PARKWAY, BRISBANE, CA
Market cap: $13.9M (12/18/2025)
Price: $3.12
Announces Up To $8.35 Million Registered Direct Offering of Common Stock and Concurrent Private Placement of Warrants Priced At-the-Market Under Nasdaq Rules
Asset Purchase Agreement with Erigen LLC and Factor Bioscience Inc.
Reports Third Quarter 2025 Financial Results and Provides Business Update
Reports Second Quarter 2025 Financial Results and Provides Business Update
News, Securities Holder Rights or Indentures, Legal Opinion, Material Contracts
Other Events
Changes in Board, Management or Compensation
Reports First Quarter 2025 Financial Results and Provides Business Update
Q3
Q2
Q1
FY 2024
FY 2023
S-1
Prospectus filed pursuant to Rule 424(b)(5)
Registration Statement for Securities to be Offered to Employees
Effectiveness Notice
Amended Registration Statement for Securities Offered under a Shelf Registration
Amended Registration of Securities
PRE 14A
Additional Proxy Materials
Definitive Proxy Statement
Statement of Changes in Beneficial Ownership
Notice of Proposed Sale of Securities
Amended Schedule 13D - Ownership Report
S-8 POS
Correspondence